Income Statement

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Jul. 31, 2017
Jul. 31, 2016
Operating costs and expenses        
Research and development $ 1,641 $ 3,424
Research and development - intellectual property acquired 104,693
General and administrative 3,629 1,880 12,757 3,531
Operating costs and expenses total 5,270 1,880 120,874 3,531
Operating loss (5,270) (1,880) (120,874) (3,531)
Other expenses (income)        
Interest income (3) (5) (10) (15)
Change in fair value of warrant liability (159) 8 (133)
Net loss from continuing operations (5,267) (1,716) (120,872) (3,383)
Loss from discontinued operations (33) (770) (449) (851)
Gain on sale of discontinued operations 100 100
Gain (loss) from discontinued operations, net 67 (770) (349) (851)
Net loss (5,200) (2,486) (121,221) (4,234)
Special cash dividend attributable to preferred stockholders (6,002)
Net loss attributable to common stockholders $ (5,200) $ (2,486) $ (121,221) $ (10,236)
Net loss per share, basic and diluted:        
Loss from continuing operations $ (0.94) $ (0.65) $ (26.65) $ (1.73)
Gain (loss) from discontinued operations 0.01 (0.29) (0.08) (0.43)
Special cash dividend attributable to preferred stockholders (3.06)
Net loss attributable to common stockholders $ (0.93) $ (0.94) $ (26.73) $ (5.22)
Weighted average shares outstanding, basic and diluted: 5,568,072 2,631,640 4,534,967 1,960,643

Source